Feedback
Settings

Settings

Goto Application

1. WO2020123730 - SOLID STATE FORMS OF REPROXALAP

PermaLink
Publication Number WO/2020/123730
Publication Date 18.06.2020
International Application No. PCT/US2019/065836
International Filing Date 12.12.2019
IPC
A61P 27/02 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
C07D 215/38 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
215Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
02having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
16with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
38Nitrogen atoms
A61K 31/47 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
CPC
A61P 27/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
C07B 2200/13
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
2200Indexing scheme relating to specific properties of organic compounds
13Crystalline forms, e.g. polymorphs
C07D 215/38
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
215Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
02having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
16with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
38Nitrogen atoms
Applicants
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH [CH]/[CH]
  • TEVA PHARMACEUTICALS USA, INC. [US]/[US] (BB)
Inventors
  • MUTHUSAMY, Anantha Rajmohan
  • KANNIAH, Sundara Lakshmi
  • PUTIKUM, Rahul Kumar Reddy
  • SAXENA, Sudhanshu
  • BANDAL, Amol
Agents
  • BREW, Michael R.
  • MEAGHER, Edward C.
  • DELUCA, Peter
Priority Data
20181104706112.12.2018IN
20191100709222.02.2019IN
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) SOLID STATE FORMS OF REPROXALAP
(FR) FORMES À L'ÉTAT SOLIDE DE REPROXALAP
Abstract
(EN) The present disclosure relates to solid state forms of Reproxalap salts, processes for the preparation thereof, pharmaceutical formulations/compositions thereof, and methods of use thereof.
(FR) La présente invention concerne des formes à l'état solide de sels de Rproxalap, des procédés pour leur préparation, des formulations pharmaceutiques/compositions phamacutiques de celles-ci, et des procédés d'utilisation correspondants.
Related patent documents
EP3894002
US20220009893
IL283421
Latest bibliographic data on file with the International Bureau
# -